NOTCH THERAPEUTICS, INC.

Profile

Company Names

NOTCH THERAPEUTICS, INC.

Addresses

300-2233 COLUMBIA STREET, VANCOUVER, A1 V5Y 0M6

Phone Numbers

778-654-8588

 

Entity Type:

CORPORATION

Industry:

OTHER

Year Incorporated:

2021

State Incorporated:

DELAWARE

Total Amount Raised:

$15,499,990.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2024-05-17 
$15,499,990.00 
$15,499,990.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KAMRAN 
 
ALAM 
EXECUTIVE OFFICER
AQUINOX PHARMACEUTICALS (USA) INC   |  AQUINOX PHARMACEUTICALS INC   |  TAYSHA GENE THERAPIES, INC.   |  NOTCH THERAPEUTICS, INC.
STEPHEN 
R. 
BIGGAR 
DIRECTOR
SYNAGEVA BIOPHARMA CORP.   |  NOTCH THERAPEUTICS, INC.
CHRIS 
 
BOND 
EXECUTIVE OFFICER
NOTCH THERAPEUTICS, INC.
BERNARD 
 
LAM 
EXECUTIVE OFFICER
NOTCH THERAPEUTICS, INC.
HEATHER 
 
LEE 
DIRECTOR
NOTCH THERAPEUTICS, INC.
DAVID 
 
MAIN 
EXECUTIVE OFFICER, DIRECTOR
AQUINOX PHARMACEUTICALS (USA) INC   |  AQUINOX PHARMACEUTICALS INC   |  ZENAURA INC   |  NOTCH THERAPEUTICS, INC.
ULRIK 
 
NIELSEN 
DIRECTOR
SILVER CREEK PHARMACEUTICALS, INC.   |  ALLOY THERAPEUTICS, INC.   |  NOTCH THERAPEUTICS, INC.
JANET 
 
ROSSANT 
DIRECTOR
NOTCH THERAPEUTICS, INC.
CAROLINE 
 
STOUT 
DIRECTOR
NEOGENE THERAPEUTICS, INC.   |  NEUROGENE INC.   |  AFFINIA THERAPEUTICS INC.   |  NOTCH THERAPEUTICS, INC.
EMILY 
 
TITUS 
EXECUTIVE OFFICER
NOTCH THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-06-17
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2024-05-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#